Related Experiment Video
Updated: May 15, 2025

06:27
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
2.5K
The Multidimensional Impact of Expanded Hemodialysis: A Comprehensive Review.
Georges Kosmadakis1, Aura Necoara1, Julien Baudenon1
1AuraSanté, Clermont Ferrand, France.
Seminars in Dialysis
|April 17, 2025
Summary
Expanded hemodialysis (HDx) with medium cut-off membranes offers superior toxin removal for chronic kidney disease (CKD) patients. This advanced therapy improves cardiovascular health and quality of life compared to conventional methods.
Area of Science:
- Nephrology
- Biomedical Engineering
- Internal Medicine
Background:
- Conventional hemodialysis and high-flux modalities have limitations in clearing middle- and large-molecular-weight toxins.
- Accumulation of uremic toxins like beta2-microglobulin and cytokines contributes to inflammation and cardiovascular complications in CKD.
- There is a need for advanced renal replacement therapies that improve toxin clearance while preserving essential proteins.
Purpose of the Study:
- To review the clinical efficacy, safety, and implications of expanded hemodialysis (HDx) using medium cut-off (MCO) membranes.
- To evaluate HDx's potential to improve outcomes for patients with chronic kidney disease (CKD).
- To synthesize findings on HDx's toxin removal capabilities, hemodynamic stability, and patient-reported outcomes.
Main Methods:
- Comprehensive review of existing literature and comparative studies on HDx.
- Analysis of studies focusing on MCO membrane performance in toxin clearance.
- Examination of data on inflammatory biomarkers, arterial compliance, cardiovascular outcomes, and patient-reported outcomes.
Main Results:
- HDx demonstrates superior clearance of middle- and large-molecular-weight toxins, including beta2-microglobulin and cytokines, compared to conventional methods.
- HDx contributes to hemodynamic stability and enhanced toxin removal via internal filtration-backfiltration.
- Significant reductions in inflammatory biomarkers, improved arterial compliance, better cardiovascular outcomes, and enhanced quality of life were observed with HDx.
Conclusions:
- Expanded hemodialysis (HDx) using MCO membranes is a promising innovation in renal replacement therapy for CKD.
- HDx offers improved efficacy in toxin removal, better patient outcomes, and cost-effectiveness, especially in resource-limited settings.
- Further research is needed on long-term data, mortality, and personalized HDx protocols to fully realize its potential.
Related Concept Videos
Dialysis
235
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
235
Heart Failure Drugs: Diuretics
298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
Factors Affecting Renal Clearance: Renal Impairment
36
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
36
Renal Failure: Dose Adjustments
38
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
38
Documentation in Long-Term and Home Healthcare Setting
835
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
835
Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K

